Your RBQM platform found the risk.
Who owns the decision?
Detection is solved at scale. The defensible decision is not. Every signal your platform fires needs a named owner, a documented action, and an audit trail. That's the operational layer that turns detection into oversight.
9,500+
platform users
1,600+
studies de-risked
142,000+
issues detected
As RBQM adoption scales, the differentiator shifts from detection to what a team does with it. The teams that get value are the ones with the governance, decision owners, and escalation pathways already in place — the operational foundation detection runs on.
From detection to the defensible decision
Your platform produces signals. Inspectors want the decision record. The operational layer that connects them is what makes detection pay off.
Fires a risk signal
Scores a site
Flags a data anomaly
Exports a detection report
Names the accountable decision owner
Defines the escalation path and timeline
Assesses clinical meaning and action
Produces the inspection-ready evidence thread
The Decision-Owner RACI & Escalation Pathway
Before a signal fires, every signal type is mapped to a named owner, a severity tier, and a response SLA. This is the table that turns “who owns this?” into a one-second question — and the documented trigger → assess → act → close path that makes the response defensible.
| KRI / Signal | Sev | Responsible | Accountable | Consulted | Informed | Response SLA |
|---|---|---|---|---|---|---|
| Enrollment velocity anomaly | Major | Site Manager | Clinical Lead | Data Mgmt, Biostat | Sponsor, QA | Assess 24h · Act 5d |
| Query rate spike | Minor | CRA | Data Manager | Clinical Lead | Sponsor | Assess 48h · Act 10d |
| Protocol deviation cluster | Major | Clinical Lead | Medical Monitor | QA, Site Manager | Sponsor, IRB | Assess 24h · Act 5d |
| SAE reporting timeliness | Critical | Safety Officer | Medical Monitor | Clinical Lead, Regulatory | Sponsor | Assess 4h · Act 24h |
| QTL breach (data quality) | Major | Data Manager | RBQM Lead | Biostat, Clinical Lead | Sponsor, QA | Assess 24h · Act 5d |
Escalation pathway — every signal follows the same governed route:
The Decision Evidence Record
The inspection-ready output a platform alone can't generate. For every signal, a documented decision record — the “prove it later” your audit trail is missing.
Signal source
RBQM KRI-04 — Site 017 enrollment velocity anomaly
Named decision owner
Dr. R. Mehta, Clinical Lead (per RACI §3.2)
Clinical assessment
True outlier — enrollment coaching required; not fraud pattern
Action taken
Triggered Site Action Plan SOP-014; retraining scheduled 2026-08-20
Evidence attached
Site CAPA form, training log, KRI trend export
Audit trail
Decision logged 2026-08-13 14:02 UTC · reviewer: BleuConsult advisory
The RBQM Readiness Pack
Built to sit on top of your RBQM platform — the operational foundation that makes your platform investment inspection-ready.
RBQM SOP set
Signal triage, issue management, and quality-decision SOPs aligned to ICH E6(R3) §2.10–2.13 — the procedures your platform’s outputs flow through.
Decision-owner RACI
Every KRI/QTL mapped to a named accountable role, so no signal lands on an unowned desk. The single biggest gap detection-only teams hit.
Escalation pathways
Documented trigger → assessment → action → closure routes with timelines, so a flag becomes a proportionate, traceable response — not a forwarded email.
Audit-trail mapping
Each signal type mapped to the evidence record and retention rule an inspector will ask for. Turns detection into a defensible thread.
BleuConsult is an independent clinical operations advisory firm and is not affiliated with, endorsed by, or a reseller of any RBQM platform vendor. Market statistics are sourced from a leading platform’s 2024 public disclosures and are used here for market context only.
Compliance & Transparency
oPoS is an advisory decision-support tool designed to assist clinical trial planning. It does not replace professional regulatory judgment. The methodology is designed to support ICH E6(R3)-aligned assessment, sponsor oversight documentation, and decision evidence. The platform may process business contact information, uploaded protocol materials, and other user-provided content. Do not upload PHI unless appropriate agreements and safeguards are in place. VeriAbyss™ provides AI-assisted consistency review; outputs remain advisory until qualified human review.
© 2026 BleuConsult. All methodologies, frameworks, assessment logic, and library materials are the proprietary intellectual property of BleuConsult. All rights reserved.
All assessments are for informational purposes only.
